WHY ORBIS?
CAPABILITIES
EXTENDED RELEASE PARENTERALS
Extended release capability for small molecules, peptides, and proteins
PULSE RELEASE PARENTERALS
Pulse release capability for vaccines and special delivery mechanisms
INTRATYMPANIC DELIVERY
Delivery of therapeutic agents for treatment of otolaryngological diseases
ENTERIC-COATED ORAL POWDERS
A wide range of modified release options using format flexible powders
TASTE-MASKED ORAL POWDERS
Don’t sacrifice taste to get a dispersed solid oral dosage form
EXTENDED RELEASE ORAL SUSPENSIONS
Match extended release tablet performance in a suspension format
TECHNOLOGY
HOW IT WORKS
Precision Particle Fabrication® technology produces uniform microspheres and microcapsules with narrow size distribution and precise control over particle structure. Orbis’ technology is an elegant and robust solution…
SCALE & MANUFACTURING
Orbis’ platform technologies have been scaled from single nozzles to variations of multi-nozzles, then another order of magnitude by simply running multi-nozzles in parallel. Housed in Orbis’ Class 100,000 (ISO 8) production suite pictured below…
PIPELINE
Orbis Biosciences has a diverse product portfolio to leverage where Precision Particle Fabrication® technology differentiates products.
We are focused on creating novel oral and injectable therapeutics to improve compliance and patient satisfaction. Our products address clinical needs and are at various stages of development. Many of the products are based on strategic partnerships with pharmaceutical companies. Products developed internally are positioned for co-development and licensing arrangements.
PRESS RELEASES
Orbis Biosciences Completes Successful Phase I Clinical Trial
LENEXA, KS – May 19, 2017 – Orbis Biosciences, Inc., is proud to announce the completion of its first-in-human clinical trial with ORB-101, its taste-masked [...]
Orbis Biosciences Named Finalist in the Fierce Innovation Awards
LENEXA, KS – December 8, 2017 – Orbis Biosciences, Inc., is a finalist for the FierceBiotech and FiercePharma (Fierce) Innovation Awards. Orbis Biosciences’ submission [...]
Orbis Biosciences and Daré Bioscience Collaborate to Advance Innovation for Reproductive Health
LENEXA, KS – March 12, 2018 – Orbis Biosciences, Inc. announced today it has granted Daré Bioscience, Inc. an exclusive option to [...]